Researchers found lidocaine increased expression of miR-539 (an EGFR suppressor) in lung cancer cells treated in vitro resulting in EGFR inhibition and reduced viability, migration and invasion as well as apoptosis (72). Here, EGFR is linked to lung carcinoma.